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We previously reported that tau protein kinase II (TPKII) from bovine brain was composed of 30 kDa and 23 kDa subunits. The 30 kDa subunit 
of TPKII can be regarded as a catalytic subunit because of its ATP-binding activity. Antibodies directed against TPKII-phosphorylated tau also 
reacted with tau phosphorylated by cdc2 kinase obtained from starfish oocytes, indicating that TPKII and cdc2 kinase phosphorylate the same 
sites. We determined the amino acid sequence of the 30 kDa subunit and found it to be homologous with a cdc2-related lcmase, PSSALRE/cdkS. 
Moreover, an antibody against PSSALRE/cdkS reacted with the 30 kDa subunit. These results indicate that the 30 kDa subunit of TPKII is bovine 
homologue of PSSALRE/cdkS. Expression of the 30 kDa subunit mRNA was enhanced in juvenile rat brain. This result supports our previous 
hypothesis that the kinase works actively in juvenile brain. 
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1. INTRODUCTION 
Paired helical filaments (PHFs) accumulate in the 
brains of Alzheimer’s disease patients. One of their 
major components is abnormally phosphorylated tau 
protein. It is important to determine the kinase phos- 
phorylating tau for elucidation of the mechanisms un- 
derlying the formation of PHF. From microtubule pro- 
tein we have purified a protein kinase phosphorylating 
tau into the PHF-like state [1,2]. We call the enzyme tau 
protein kinase (TPK) I. TPKI has been found to be 
identical to glycogen synthase kinase (GSK) 38 [3]. 
Other groups also reported that GSK3 is involved in 
PHF formation [4,5]. In addition to GSK3, mitogen- 
activated protein (MAP) kinase has also been consid- 
ered as a candidate for an enzyme involved in abnormal 
phosphorylation of tau [6-91. During the purification of 
TPKI/GSK3B, we identified another protein kinase 
named TPKII [2]. Prior phosphorylation of tau by 
TPKII enhanced phosphorylation by TPKI/GSK3/?, in- 
dicating that TPKII may regulate the phosphorylation 
state of tau not only in normal brain but also in Alz- 
heimer’s diseased brain [lo], though indirectly. More- 
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2.1. Materials 
***Present address: Department of Agricultural Chemistry, the Uni- Bovine tau, TPKI and TPKII were puritied by the method described 
versity of Tokyo, Bunkyo-ku, Tokyo 113, Japan. previously [2]. Starfish oocyte cdc2 kinase was a kind gift from Drs. 
over, we determined phosphorylation sites on tau by 
TPKII, Ser-202, Thr-205, Ser-235 and Ser-404 [l 11, and 
later phosphorylation sites by TPKI/GSK3fi, Ser- 199, 
Thr-23 1, Ser-396 and Ser-413 [12]. The amino acid 
numbering is in the longest human tau isoform [13]. 
Phosphorylation of most of these sites in PHF-tau are 
supported by other groups [14-171. In order to under- 
stand the phosphorylation mechanism observed in 
PHF-tau, it is important to determine the identity of 
TPKII. 
The kinase is composed of two subunits, whose mo- 
lecular weights are 30 kDa and 23 kDa determined by 
their mobilities on SDS-PAGE. The 30 kDa subunit 
bound to an ATP-analogue, suggesting that the subunit 
was a catalytic one. One of the best substrates of TPKII 
was histone Hl [2]. The kinase phosphorylated serinel 
threonine proline sequence [11,18]. These results sug- 
gest that the kinase resembles cdc2 kinase. Here, we 
show that the sequence of 30 kDa subunit is identical 
to brain-proline directed protein kinase from bovine 
brain [19], which is just homologous with PSSALRE 
from human cell line [20], cyclin-dependent kinase 5 
(cdk5) of human fibroblasts [21] and neuronal cdcZlike 
kinase (nclk) from rat brain cDNA library [22]. 
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T. Kishimoto and S. Hisanaga (Tokyo Institute of Technology). The 
kinase was prepared according to the method described elsewhere [23] 
with some modification (Okumura and Kishimoto, in preparation). 
Antibodies specific to TPKII-phosphorylated tau sites, anti-PS202, 
anti-PT205, anti-PS404, were described in our previous paper as anti- 
PS144, antiPT147 and anti-PS315, respectively [lo]. The amino acid 
numbering in this paper is in the longest human tau [13], whereas that 
in the previous paper was in the shortest human tau [24]. Anti-human 
cyclin D antibody was purchased from UBI. 
2.2. Sequencing 
The TPKII-30 kDa subunit was separated from 23 kDa subunit by 
reverse-phase column (C4, Aquapore BU-300,2.1 x 30 mm, Applied 
Biosystems) chromatography with 0.9 ml linear gradient of l&70% 
acetonitrile in 0.1% trifluoroacetic acid, and digested with Acro- 
mobacter protease I (API) (Wake Pure Chemical Industries) or pro- 
tease V8 (Boehringer Mannheim) in the reaction mixture of 4 M urea, 
20 mM methylamine, 1 mM ethylenediaminetetraacetic acid and 40 
mM sodium phosphate buffer @H 8.5) at protein weight ratio of 1O:l 
at 37’C for 18 h. Several peptides were purified from the digest by 
reverse-phase column (C8, Aquapore RP-300, 2.1 x 30 mm, Applied 
Biosystems) chromatography under the same condition mentioned 
above. The amino acid sequences were determined by a pulse-liquid- 
phase amino acid sequencer (Applied Biosystems 477A protein se- 
quencer). 
Primers 1 and 2 and probe B were chemically synthesized based on 
1 
91 
136 
181 
226 
271 
probe A 
primer 1 
GGAGTCTTAGAACCCAG-GGCCCGCAAGTCCTCGCGCGGCTGCCGTG 46 
primer 2 
I 
4 
T- C-----+ 
ATGCAGAAATACGAGAAACTGGAGAAGATT~AA~ACCTAC~AACA~GTTCAA~CCAAAAACC~AGACTCATGAGA~GT~TCTGAAAC~TGA~T~ATGACGATGACGA~TGT~CG 181 
HQKYEKLEKIGEGT.YGTVFKAKNRETHEIVALKRVRLDDDDEGV~ 
K8 ___ 
El 1 --- El3 
KlO 
the sequences of human cdc2-related kinase, PSSALRE [20] (see Fig. 
1). Probe A was synthesized as a double-stranded form by primer 
extension of the annealed complex of primers 1 and 2 using the Kle- 
now fragment and 4 dNTPs including labelled dCTP. cDNA of bovine 
TPKII30 kDa subunit was cloned from a bovine brain cortex cDNA 
library (Clontech) using probes A and B. DNA was sequenced by 
dideoxy-mediated sequencing [25]. 
2.3. Other methods 
Peptides were synthesized by the solid phase method, using a Bio- 
search model 9500 peptide synthesizer. For immunization, the syn- 
thetic oligopeptides were covalently crosslinked to the carrier protein, 
keyhole limpet hemocyanin, and injected into the footpad and fingers 
of rabbits every three weeks and for a total of three times. Im- 
munoblotting was performed with ABC kit (Vector Laboratories). 
Total RNA was extracted from rat brain by the acid guanidinium 
thiocyanate-phenol-chloroform method [26]. Using magnetic oligo dT 
beads (Dynabeads, Dynal), poly(A)+ RNA was separated from the 
total RNA. 
3. RESULTS 
TPKII resembles cdc2 kinase as judged from two 
aspects: (i) that it is also a proline-directed Ser/Thr ki- 
nase [l l] and (ii) that its best substrate is histone Hl [2]. 
peptide 1 
TTCGACAGCTGCAATGGTGACCTAGATCCTGAAATT~GAAGTCA~~TCTTCCA~T~TGAAA~CT~~CTGTCACA~CGAAA~T~T~ACA~CCTGAA~CTCA~ACCT~TCATCAAC 451 
FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 
AGGAATGGGGAGCTGAAACTGGCTGATTTT~~~TC~~C~T~GATCCCTGTT~TG~ACTCA~TGAffiTC~CAC~TGT~TACC~ACCTGAT~CCTC~~AA~TGTACTCC 586 
RNGELKLADFGLARAFGIPVRCYSAEVVTLNYRPPDVLFGAKLYS 
ACGTCCATCGACATGT~CAGCTGGCTGCATCTT~AGA~T~CAAC~T~~CCTC~~T~AATGAT~AGAC~CCA~TGAAGA~ATC~CffiACTCCT~AC~CAACCGA~AG 721 
TSIDNUSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 
< 
probe B A--l 
CAGTGGCCT~CATGACCAAGT~CA~CTATAA~CCTA~CCGATGTACCCTAAC 
QUPAHTKLPDYKPYPHYPATTSLVNVVPKLNATGRDLLQNLLKCN 856 
peptide 2 
CCGGTCCAGCGCATCTCGGCGGAGGAGGCCCTGCAGCATCTCCGACTTCTGCCCCCCCTA~TCCA~~T~C~T~CAC~GAC~CCCCTCT~A~GAAA~CA~AT~AC 
I 
991 
PVQRISAEEALQHPYFSDFCPPf 
El5 292 
1100 
CGTGTGCTGAGCTCAGCTGTGCTGGGCCGGTCAGGGTGGA~T~CCTCACCCGTGGTCTTCACTCCCTCCGT~ACTTTAT~AAT~CATAAATTGGCTCC~TCCC 
Fig. 1. Sequence of bovine TPKII-30 kDa subunit. K8 and KlO indicate sequences of peptides obtained from API digests. El 1, El3 and El5 indicate 
sequences of peptides obtained from V8 digests. Peptides 1 and 2 are antigens for preparation of anti-30 kDa subunit and anti-PSSALRE/cdkS, 
respectively. An oligonucleotide probe A was prepared by primer extension of the annealed complex of primer 1 and primer 2. Probes A and B 
were used for cDNA cloning. Differences in sequence between probes or primers and cDNA are indicated by characters in arrows. The sequence 
of 5’-non-coding and coding regions is completely identical to that of brain-proline directed protein kinase [19]. In the 3’-non-coding region, a 
triangle indicates the addition of a single nucleotide, and the downstream sequence beyond the vertical line has not yet been reported. 
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A. Protein 
6. a-PS404 
Fig. 2. Comparison between TPKII and cdc2 kinase on phosphoryla- 
tion of tau. Bovine tau was phosphorylated by TPKII, TPKI or cdc2 
kinase. (A) Protein staining of these. tau preparations on SDS-PAGE 
by Ag stain Daiichi (Daiichi Kagaku). (B) Immunostaining of tau with 
anti-P%@4 @PS404), an antibody specitic to the phosphorylation 
site, Ser-404. 
We first checked that cdc2 kinase phosphorylated the 
same sites on tau that TPKII phosphorylated. We re- 
ported three antibodies specific for the phosphorylation 
sites; anti-PS202, anti-PT205 and anti-PS404. Previ- 
ously we called these anti-PS144, antiPT147 and anti- 
PS315, respectively [lo], according to the amino acid 
numbering of the shortest human tau [24]. Fig. 2 shows 
that anti-PS404 also reacted with tau phosphorylated by 
statish oocyte cdc2 kinase, as anti-PS202 and anti- 
PT205 did (data not shown), indicating that TPKII has 
a similar function to cdc2 kinase. 
The 30 kDa subunit was separated from the 23 kDa 
subunit using reverse-phase column chromatography. 
The 30 kDa subunit was digested with lysylendopepti- 
dase (API) or protease V8, and several peptides ob- 
tained from the digests were sequenced. A search for 
homologous proteins based on the sequences of these 
peptides revealed that these sequences are found in 
PSSALRE, a cdc2-like protein kinase, which was dis- 
covered from human cDNA clones with polymerase 
chain reaction (PCR) amplification using two oligonu- 
cleotide primers corresponding to conserved sequences 
of the cdc2 kinase family [20] (Fig. 1). Later, this kinase 
was found to associate with cyclin D, so it has been 
called cyclin-dependent kinase 5, cdk5 [21]. 
To confirm that the 30 kDa subunit is identical to 
PSSALRElcdk5, we next prepared antibodies against 
the 30 kDa subunit and PSSALRE/cdkS. One antibody 
was prepared against peptide 1 corresponding to the 
sequence which we had determined. Another antibody 
was raised against peptide 2, present in the sequence of 
PSSALRE/cdkS but not found in the digests of TPKII. 
Immunoblot analysis showed that both antibodies re- 
acted with the 30 kDa subunit, confIrming the identity 
between the 30 kDa subunit and PSSALRE/cdkS (Fig. 
3). 
Next we cloned TPKII cDNA from a library of bo- 
vine brain cortex using two oligonucleotide probes A 
and B corresponding to peptides 1 and 2, respectively. 
From 6 x 10’ cDNA clones, we obtained two clones 
which hybridized with both probes. Sequencing of the 
cDNAs revealed that the nucleotide sequence is almost 
identical to that of PSSALRE/cdkS [20], and that amino 
acid sequence deduced from the nucleotide sequence is 
identical except for a few residues. At the sequence 86 
to 92, our bovine clone has DLKKYFD, while human 
PSSALRE has DLK-NFD [20]. Amino acid residue 229 
is Ala in ours, but Ser in human PSSALRE. The nucle- 
otide sequence of our clone is completely identical to 
that of bovine brain-proline directed protein kinase [ 191, 
except that ours is 14 nucleotides shorter in the S-non- 
coding region and 143 nucleotides longer in the 3’-non- 
coding region including one nucleotide addition at no. 
943. Based on the sequence, the molecular weight of 
TPKII-30 kDa subunit is ca. 33,300. 
These results indicate that the 30 kDa subunit is the 
bovine homologue of PSSALRE/cdkS. cdk5 associates 
with cyclin D in fibroblasts [21]. However, the purified 
TPKII fraction from brain contained a 23 kDa protein 
A. Protein B. Immunoblot 
lM2M 
30kd 
23kd 
.:-50kd :g 
Fig. 3. Immunoblot analyses of TPKII. (A) Protein staining of TPKII 
on SDS-PAGE. Two polypeptides (30 kDa and 23 kDa) of TPKII are 
indicated. (B) Immunoblotting of 30 kDa polypeptide. TPKII were 
immunostained with antibodies raised against peptide 1 (lane 1, 1:30) 
and against peptide 2 (lane 2, 1:30). Lanes M indicate positions of 
prestained molecular weight markers (BRL, 50, 29 and 14 kDa). 
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Fig. 4. Developmental change of expression of mRNA of TPKII30 kDa subunit in rat brain. Poly(A)+ RNA was prepared from rat brains at 
embryonic day 15 and 18, and postnatal day I, 4, 7, 14,21, and month 2, 5, 13, 27. 1.5 &g of poly(A)+ RNA were subjected to Northern analysis 
using an EcoRI fragment (1.1 kbp) of bovine TPKII cDNA as a probe. 
[2] instead of cyclin D (M-W. 35 kDa). The 23 kDa 
protein was not immunostained with anti-human cyclin 
D antibody. 
Northern analysis using the cDNA probe revealed 
that the major form of mRNA of PSSALRE/cdkS is 1.8 
kb with the minor form of 3.0 kb in rat brain. These 
sizes are identical to those of rat PSSALRE/cdkS (nclk) 
mRNAs [22]. The Northern analysis also revealed that 
the mRNAs were the most abundant in the juvenile 
period (Fig. 4), confirming our previous observation 
that the kinase works actively at this period [lo]. 
4. DISCUSSION 
We present here evidence that the 30 kDa subunit of 
TPKII is the bovine homologue of PSSALRE/cdkS. 
PSSALRElcdkS was originally found as a cdc2-related 
kinase having PSSALRE sequence instead of the 
PSTAIRE sequence shared by the wellknown cdc2-re- 
lated kinases [20]. Later, the PSSALRE kinase was re- 
ported to be associated with cyclin D in human cells and 
has been called cyclin-dependent kinase 5 (cdk5) [21]. 
Considering this history, we will call the 30 kDa subunit 
PSSALRE/cdk 5. 
From bovine brain, Lew et al. also purified a cdc2 
kinase homologue, its components were a 33 kDa sub- 
unit and a 25 kDa subunit [27]. Later, the 33 kDa sub- 
unit was found to be PSSALRElcdkS [19]. Although 
PSSALRElcdk5 associated with cyclin D in fibrobiasts, 
TPKII and Lew’s enzyme fraction did not contain cy- 
clin D. Instead, PSSALRElcdkS was associated with 
another subunit, the molecular weight of which is esti- 
mated with SDS-PAGE to be 23 kDa by us [2] and 25 
kDa by Lew et al [27]. The 23 kDa subunit seems to be 
important for kinase activity. Using antibodies against 
PSSALRElcdkS, it was found that most of the 30 kDa 
protein existed alone as an inactive monomer. On the 
other hand, the kinase was activated when it coexisted 
174 
with the 23 kDa protein, suggesting that the 23 kDa 
component is necessary for the kinase activity (in prep 
aration). Moreover, the molecular weight of TPKII was 
50,000 on gel filtration [2]. These results suggest that 
TPKII is a complex of PSSALRE/cdkS and the 23 kDa 
subunit. PSSALRE/cdkS was also reported to be associ- 
ated with proliferating cell nuclear antigen (PCNA) in 
fibroblasts [21]. PCNA (M.W. 36 kDa) is, however, 
different from the 23 kDa subunit in the molecular 
weight. The identity of 23 kDa subunit remains unclear. 
Further study is in progress. 
PSSALRElcdkS cDNA was also cloned from a rat 
brain cDNA library as a neuronal cdcZlike kinase 
(nclk), which was expressed at high levels in neurons 
[22]. Since PSSALRE/cdkS was purified because it was 
enzymatically the most active cdc2-like kinase from 
brain [19,27], it s quite reasonable to think that it is the 
most prominent cdd-related protein kinase in the 
brain. In neurons, the accessory protein of PSSALREI 
cdk5 is not cyclin but a 23 kDa 123 or a 25 kDa subunit 
[27], which does not function as a cyclin because neu- 
rons are terminally differentiated cells and no longer in 
the cell cycle. 
Another substrate for TPRII is neurofilament sub- 
unit H (NF-H) [28]. NF-H is highly phosphorylated in 
axons but not in dendrites and cell bodies [29]. Phos- 
phorylation decreased its electrophoretic mobility sig- 
nificantly and weakened the interaction between neu- 
rolilament and microtubule. Hisanaga et al. showed 
that starfish oocyte cdc2 kinase was responsible for the 
phosphorylation [30]. Later, TPKII was found to phos- 
phorylate NF-H in a manner similar to cdc2 kinase 
[28,31]. Further support comes from a report that 
PSSALRE/cdkS from bovine brain phosphorylated 
NF-H [19]. It is likely that TPKII rather than another 
cdcZlike kinase is responsible for the phosphorylation 
of tau and NF-H in vivo. Both tau and NF-H are spe- 
cifically localized to neurons [32,33] with tau being most 
Volume 335, number 2 FEBSLETTERS December 1993 
abundant in axons. PSSALRE/cdkS is localized pre- 
dominantly in neural tissue [22] and TPKII is associated 
with tau on microtubule surfaces [l] and also seems to 
be close to NF-H in axons. 
A proline-directed protein kinase (‘p34*c2/p58”y”“” A) 
was reported to phosphorylate Ser-202, Thr-205, Thr- 
231 and Ser-235 on tau [34]. Phosphorylation of these 
sites is thought to be important for conversion of nor- 
mal tau into PHF-tau. Others have also pointed out the 
importance of cdc2 kinase for the conversion [7]. Phos- 
phorylation of tau by TPKII enhanced phosphorylation 
by TPKI/GSK3/? which converts normal tau into PHF- 
tau [lo]. Although TPKYGSK3p is critical for conver- 
sion of tau into PHF-tau [2,4,5], TPKII is also impor- 
tant for the first step of phosphorylation of tau. From 
this point, it is cooperation of TPKII and TPKUGSK3p 
that induces tau into the PHF-like state. 
The conversion is also induced by mitogen-activated 
protein kinase (MAP kinase) [6-91; sometimes called 
extracellular signal-regulated protein kinase (ERK). It 
remains unresolved which kinase(s) works in Alz- 
heimer’s disease brain, MAP kinase or TPKIIGSK3B 
and TPKII. Takashima et al. reported that TPKU 
GSK3B increased in /I amyloid-mediated neuronal 
death [35]. If the phosphorylation of tau participates in 
the neuronal death, not only TPKIIGSK3p but also 
TPKII should be important for the process. 
The phosphorylation state of tau in Alzheimer’s dis- 
ease brain is similar to that in juvenile brain [36]. We 
found that phosphorylation by TPKII was enhanced in 
juvenile brain [lo]. This is supported by our observation 
that mRNA of PSSALRE/cdkS was abundant in young 
brain. Common features between juvenile brain and 
Alzheimer’s disease brain are sprouting [37] and neu- 
ronal death. It is likely that TPKII and TPKI/GSK3B 
is involved in somatodendritic sprouting and/or neu- 
ronal death. 
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